Detalhe da pesquisa
1.
Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation.
Catheter Cardiovasc Interv
; 101(7): 1214-1220, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125605
2.
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
Eur Heart J
; 43(13): 1307-1316, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34617993
3.
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
Eur Heart J
; 38(42): 3124-3134, 2017 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29020367
4.
Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.
Catheter Cardiovasc Interv
; 88(3): E67-73, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26526783
5.
Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification.
Circ J
; 80(2): 354-62, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26725763
6.
Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
Am Heart J
; 166(4): 669-75, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24093846
7.
A new integrative approach to assess aortic stenosis burden and predict objective functional improvement after TAVR.
Front Cardiovasc Med
; 10: 1118409, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36937938
8.
First description and validation of a new method for estimating aortic stenosis burden and predicting the functional response to TAVI.
Front Cardiovasc Med
; 10: 1215826, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38034386
9.
Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study).
Am J Cardiol
; 162: 31-40, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903344
10.
Papillary muscle rupture: first report of this complication in a retrograde transfemoral aortic valve implantation.
Catheter Cardiovasc Interv
; 78(4): 647-9, 2011 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21413137
11.
First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study.
Cardiovasc Revasc Med
; 32: 18-24, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386256
12.
Validation study to determine the accuracy of central blood pressure measurement using the SphygmoCor XCEL cuff device in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
J Clin Hypertens (Greenwich)
; 23(6): 1165-1175, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942487
13.
Scoring balloon predilation before bioresorbable vascular scaffold implantation in patients with in-stent restenosis: the RIBS VI 'scoring' study.
Coron Artery Dis
; 32(2): 96-104, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558692
14.
Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study.
Acta Cardiol
; 65(4): 387-94, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20821930
15.
Outcomes of predefined optimisation criteria for intravascular ultrasound guidance of left main stenting.
EuroIntervention
; 16(3): 210-217, 2020 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32011286
16.
Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
Cardiovasc Revasc Med
; 21(4): 508-513, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31401071
17.
First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial.
EuroIntervention
; 15(12): e1081-e1089, 2019 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31310239
18.
Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis.
Thromb Res
; 177: 180-186, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30925398
19.
Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease.
JACC Cardiovasc Interv
; 12(3): 259-270, 2019 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409759
20.
Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies.
Catheter Cardiovasc Interv
; 72(4): 459-67, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18814274